Steven M. Horwitz, MD, Memorial-Sloan Kettering Cancer Center, focuses on the care of patients with all types of lymphomas. More specifically, his research focuses on developing a better understanding of new therapies for patients with T-cell lymphomas and cutaneous lymphomas.
Dr. Horwitz has led numerous clinical trials, and his research has appeared in a number of medical publications, including Blood, Journal of Clinical Oncology, and the Journal of the American Academy of Dermatology among others. He is a member of the NCCN non-Hodgkin lymphoma guidelines committee and has authored or co-authored many of the national guidelines for cutaneous lymphomas.
Dr. Horwitz has been a longtime friend of the CLF and has distinguished himself as a global leader in both physician and patient education on the topic of cutaneous T-cell lymphoma. He has participated in numerous CLF patient education forums and has written for the CLF Forum newsletter. He has also generously donated his time to participate in numerous webcasts, podcasts and workshops providing education, advocacy and support to the CTCL community. He has also served on the board of the U.S. Cutaneous Lymphoma Consortium (USCLC) and served on various committees for the International Society for Cutaneous Lymphomas.
This is an automatic translation service and therefore the
Cutaneous Lymphoma Foundation is not responsible
for any potential translation inaccuracies.